Technetium-99m-RPI-T-087

N/A

Report date: 2025/11/24 17:58:16
NME

Base Information

Drug NameTechnetium-99m-RPI-T-087
Drug Alias Name[99mTc]RPI-T-087[Tc-99m]-RPI-087Tc-99m -RPI-T-087[Tc-99m]-RPI-T-087T-087
ClassificationSmall moleculesDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsCyclooxygenase-2
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesReiley Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReiley Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A